Bone Bonding of Biomaterials And Apatite Formation On Biomaterials

1999 ◽  
Vol 599 ◽  
Author(s):  
Takashi Nakamura ◽  
Masashi Neo ◽  
Tadashi Kokubo
Keyword(s):  
Bonding Strength ◽  
Bone Cells ◽  
Bone Marrow Cells ◽  
Inorganic Ions ◽  
Apatite Layer ◽  
Apatite Formation ◽  
Bioactive Ceramics ◽  
Transmission Electron ◽  
Bone Apatite

AbstractBioactive ceramics are known, which can bind bone tissue chemically. The authors tested bone-bonding strength of biomaterials using detaching test and observed the interface between bone and bioactive ceramics with transmission electron microscopy. An intervening apatite layer was observed at the interface of bone and bioactive ceramics. This layer was distinguished from bone apatite or ceramic. This apatite layer was formed within several days after implantation before bone was observed on the materials. Bisphosphonate is well known to inhibit apatite formation. The injection of bisphosphonate to rabbits concentrationdependently decreased bone-bonding strength of ceramics. The apatite layer was formed on bioactive ceramics in vitro by immersing them in simulated body fluid that contained similar concentrations of inorganic ions as plasma did. Using this apatite layer formed in vitro, it is possible to characterize the apatite layer. This apatite layer enhanced the differentiation of rat bone marrow cells to bone cells in vitro. When osteoclasts were cultured on this layer, they absorbed the apatite layer.These results suggested this apatite layer not only plays a key role for bone bonding but also behaved as bone-like tissues.

Study of Bio-Mineralization of BCP with Compensation of Calcium and Phosphate Ions

2009 ◽  
Vol 610-613 ◽  
pp. 1391-1394
Author(s):  
Hua De Zheng ◽  
Ying Jun Wang ◽  
Qiang Ma ◽  
Cheng Yun Ning ◽  
Xiao Feng Chen
Keyword(s):  
Free Energy ◽  
Calcium Phosphate ◽  
Calcium Ions ◽  
Biphasic Calcium Phosphate ◽  
Porous Ceramic ◽  
Apatite Layer ◽  
Apatite Formation ◽  
Phosphate Ions

In the present study, an Intelligent Multi-parameter Simulated Evaluation in vitro （IMSE system） was used to study the deposition properties of apatite formation on the surface of biphasic calcium phosphate porous ceramic (BCP) from static and dynamic r-SBF. Results showed that apatite formed on the surface of BCP from static and dynamic r-SBF differed between each other. In static r-SBF, ions were transferred by diffusion, which could not compensate the consuming of calcium ions, and mist apatite layer was formed on the surface of samples. But in the dynamic r-SBF, simulated fluid was adjusted precisely and flowed forcedly, the concentrations of ions were homogeneous; with the compensation of ions, calcium and phosphate were supersaturated, and the free energy of apatite formation was negative, bone-like apatite sheets were formed on the surface of samples.

Apatite-Forming Ability of Organic-Inorganic Hybrids Prepared from Calcium Silicate and Glucomannan

2007 ◽  
Vol 361-363 ◽  
pp. 567-570
Author(s):  
Yasuyuki Morita ◽  
Toshiki Miyazaki ◽  
Eiichi Ishida ◽  
Chikara Ohtsuki
Keyword(s):  
Calcium Silicate ◽  
Body Fluid ◽  
Organic Polymer ◽  
Apatite Formation ◽  
X Ray Diffraction ◽  
Electron Microscopic ◽  
Living Body ◽  
Bioactive Ceramics ◽  
Previously Treated

So-called bioactive ceramics are used for bone-repairing owing to attractive features such as direct bone-bonding in living body. However, there is limitation on clinical applications due to their inappropriate mechanical properties performances such as higher brittleness and lower fracture toughness than natural bone. To overcome this problem, hybrid materials have been developed by modification of calcium silicate, that is basic component of bioactive ceramics, with organic polymer. It is known that bioactive ceramics bond to bone through bone-like apatite layer which is formed on their surfaces by chemical reaction with body fluid. We attempted preparation of bioactive organic-inorganic hybrids from Glucomannan that is a kind of complex polysaccharide, and calcium silicate. Hybrids were prepared from glucomannan and tetraethoxysilane (TEOS). They were treated with 1M (=mol·m-3) CaCl2 aqueous solution for 24 hours. Then ability of apatite formation on the hybrids was examined in vitro using simulated body fluid (SBF, Kokubo solution). Surface structure of the specimens was examined by thin-film X-ray diffraction (TF-XRD), scanning electron microscopic (SEM) observation. The hybrids with TEOS:Glucomannan= 1:1 to 4:1 in mass ratio formed the apatite in SBF within 3 or 7 d, when they were previously treated with CaCl2 solution.

scholarly journals Fabrication, Mechanical Properties and In-Vitro Behavior of Akermanite Bioceramic

Materials ◽  
2020 ◽  
Vol 13 (21) ◽  
pp. 4887
Author(s):  
Fariborz Tavangarian ◽  
Caleb A. Zolko ◽  
Sorour Sadeghzade ◽  
Marwan Fayed ◽  
Keivan Davami
Keyword(s):  
Electron Microscopy ◽  
Mechanical Properties ◽  
Subsequent Annealing ◽  
Apatite Formation ◽  
X Ray ◽  
Transmission Electron ◽  
Powder Samples ◽  
Sbf Solution ◽  
Scanning Electron

Pure nanocrystalline akermanite (Ca2MgSi2O7) powder was synthesized by mechanical activation with subsequent annealing of talc, calcium carbonate, and silicate powders as the initial materials. Powder samples were characterized by X-ray diffractometry (XRD), scanning electron microscopy (SEM), thermogravimetric analysis (TGA), and transmission electron microscopy (TEM) techniques. The results showed that pure nanocrystalline akermanite with a crystalline size of 35 nm was synthesized after ball milling the initial powders for 20 h with subsequent annealing at 900 °C for 1 h. Mechanical properties of bulk akermanite samples were studied as well. The results showed that the produced akermanite tablets sintered at 1200 °C for 5 h had a Young’s modulus of 3800 MPa, an ultimate compressive strength of 24.7 MPa, and a density of 2.489 g/cm3. The in-vitro behavior of the produced akermanite was evaluated by soaking the samples in an SBF solution. The results showed that the produced akermanite had the apatite formation ability on its surface and can be a good candidate for bone tissue engineering applications.

scholarly journals Syndecan-1 Is a Multifunctional Regulator of Myeloma Pathobiology: Control of Tumor Cell Survival, Growth, and Bone Cell Differentiation

Blood ◽  
1998 ◽  
Vol 91 (8) ◽  
pp. 2679-2688 ◽  
Author(s):  
Madhav V. Dhodapkar ◽  
Etsuko Abe ◽  
Allison Theus ◽  
Marie Lacy ◽  
J. Kevin Langford ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Heparan Sulfate ◽  
Bone Disease ◽  
Bone Cells ◽  
Bone Marrow Cells ◽  
Myeloma Cells ◽  
Bone Cell Differentiation ◽  
Dose Dependent

Multiple myeloma is characterized by an accumulation of malignant plasma cells in the bone marrow coupled with an altered balance of osteoclasts and osteoblasts, leading to lytic bone disease. Although some of the cytokines driving this process have been characterized, little is known about the negative regulators. We show that syndecan-1 (CD 138), a heparan sulfate proteoglycan, expressed on and actively shed from the surface of most myeloma cells, induces apoptosis and inhibits the growth of myeloma tumor cells and also mediates decreased osteoclast and increased osteoblast differentiation. The addition of intact purified syndecan-1 ectodomain (1 to 6 nmol/L) to myeloma cell lines in culture leads to induction of apoptosis and dose-dependent growth inhibition, with concurrent downregulation of cyclin D1. The addition of purified syndecan-1 in picomolar concentrations to bone marrow cells in culture leads to a dose-dependent decrease in osteoclastogenesis and a smaller increase in osteoblastogenesis. In contrast to the effect on myeloma cells, the effect of syndecan-1 on osteoclastogenesis only requires the syndecan-1 heparan sulfate chains and not the intact ectodomain, suggesting that syndecan's effect on myeloma and bone cells occurs through different mechanisms. When injected in severe combined immune deficient (scid) mice, control-transfected myeloma cells (ARH-77 cells) expressing little syndecan-1 readily form tumors, leading to hind limb paralysis and lytic bone disease. However, after the injection of syndecan-1–transfected ARH-77 cells, the development of disease-related morbidity and lytic bone disease is significantly inhibited. Taken together, our data demonstrate, both in vitro and in vivo, that syndecan-1 has a significant beneficial effect on the behavior of both myeloma and bone cells and therefore may represent one of the central molecules in the regulation of myeloma pathobiology.

In-Vitro Study of Sol Gel Synthesized Bioactive Glass Ceramics for Anti-Microbial Properties

2021 ◽  
Vol 21 (3) ◽  
pp. 1606-1612
Author(s):  
Narender Ranga ◽  
Atul Kumar ◽  
C. R. Mariappan ◽  
Surender Duhan
Keyword(s):  
Structural Information ◽  
Sol Gel ◽  
Research Work ◽  
Glass Ceramics ◽  
In Vitro Study ◽  
Apatite Formation ◽  
E Coli ◽  
Transmission Electron ◽  
New Type

In this research work new type of bioglass ceramics successfully synthesized the bioglass composition: 50SiO2−30CaO−10P2O5−10MgO by sol–gel technique which was further heated up to 600 °C. Different characterization techniques were applied on the prepared bioglass powder to obtain the structural information. X-ray powder diffraction (XRD) and fourier-transform infrared spectroscopy (FTIR) analysis confirms the amorphous nature and apatite formation on surface of the sample. The time dependent biological activity was tested on immersed samples with simulated body fluid (SBF). Structural configuration of the hydroxyapatite layer along with nano-size as well as texture properties of the samples were confirmed using field emission scanning electron microscope (FE-SEM), high-resolution transmission electron microscopy (HR-TEM) and Brunauer–Emmett–Teller (BET) techniques, respectively. It was found that magnesium performs a pivotal role in bone proliferation and improves the thermophysical properties of the synthesized bioglass ceramics. The antibacterial effects were studied by two well-known pathogen Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus).

scholarly journals Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2

1998 ◽  
Vol 158 (3) ◽  
pp. R1-R5 ◽  
Author(s):  
K Ono ◽  
T Akatsu ◽  
T Murakami ◽  
M Nishikawa ◽  
M Yamamoto ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Bone Cells ◽  
Bone Marrow Cells ◽  
Therapeutic Potential ◽  
Cell Formation ◽  
Mouse Bone Marrow ◽  
Dependent Manner ◽  
Clinical Conditions

Of various PGs, PGE1 and PGE2 are shown to be the most potent stimulators of osteoclastogenesis in vitro. PGE receptors have been classified into four subtypes, EP1-EP4. Little is known about PGE receptors functioning in bone cells. In this study, using mouse marrow culture, we investigated which PGE receptors are important in osteoclast-like cell (OCL) formation induced by PGE. 11-deoxy-PGE1 (EP2, EP3 and EP4 agonist) stimulated OCL formation potently. Butaprost (EP2 agonist) stimulated it slightly, while sulprostone (EP1 and EP3 agonist) and ONO-AP-324-01 (EP3 agonist) did not. AH23848B (EP4 antagonist) inhibited PGE2-induced OCL formation in a dose-dependent manner. The expression of EP4 mRNA in mouse bone marrow was confirmed by RT-PCR. The results indicate an important role of EP4 in PGE2-induced OCL formation in marrow cultures and suggest therapeutic potential of EP4 antagonists in some clinical conditions with accelerated bone resorption.

scholarly journals Quenched/unquenched nano bioactive glass-ceramics: Synthesis and in vitro bioactivity evaluation in Ringer’s solution with BSA

2013 ◽  
Vol 19 (2) ◽  
pp. 231-239 ◽  
Author(s):  
Nima Nabian ◽  
Maedeh Delavar ◽  
Mahmood Rabiee ◽  
Mohsen Jahanshahi
Keyword(s):  
Electron Microscope ◽  
Bioactive Glass ◽  
Glass Ceramic ◽  
Sol Gel ◽  
Glass Ceramics ◽  
Apatite Formation ◽  
In Vitro Bioactivity ◽  
Sem Images ◽  
Transmission Electron

The paper reports the first attempt at changing cooling treatment of synthesizing method in order to investigate its effect on the physical properties of sol-gel derived nano bioactive glass-ceramic in the system 58SiO2-33CaO-9P2O5 (wt.%). We hypothesized that the method of cooling may affect the properties of nano bioactive glass-ceramic. To test this hypothesis, two different method of cooling treatment was applied after calcinations in synthesizing method. Both quenched and unquenched nano bioactive glass-ceramics were soaked in Ringer?s solution with bovine serum albumin (BSA) for bioactivity evaluation. The obtained samples were analyzed for their composition, crystalinity and morphology through X-ray powder diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), surface electron microscope (SEM) and transmission electron microscope (TEM). The SEM images showed that the morphology of nano bioactive glass-ceramics was completely changed by quenching process. Results of in vitro bioactivity evaluation revealed that the unquenched attains faster apatite formation ability than the quenched sample. Other properties of these two morphologically different nano bioactive glass-ceramics were strongly discussed.

Synthesis and Characterization of Sol-Gel Derived Hydroxyapatite-Bioglass Composite Nanopowders for Biomedical Applications

2012 ◽  
Vol 12 ◽  
pp. 51-57 ◽  
Author(s):  
S. Adibnia ◽  
Ali Nemati ◽  
Mohammad Hosseien Fathi ◽  
S. Baghshahi
Keyword(s):  
Electron Microscopy ◽  
Inductively Coupled Plasma ◽  
Biomedical Applications ◽  
Sol Gel ◽  
In Vitro Study ◽  
Apatite Formation ◽  
X Ray Diffraction ◽  
Inductively Coupled ◽  
Transmission Electron

The main purpose of this study is to prepare and characterize hydroxyapatite (HA)–10%wt bioglass (BG) composite nanopowders and its bioactivity. Composites of hydroxyapatite with synthesized bioglass are prepared at various temperatures. Suitable calcination temperature is chosen by evaluating of the phase composition. X-ray diffraction (XRD), Transmission electron microscopy (TEM) and Scanning electron microscopy (SEM) techniques are utilized to characterize the prepared nanopowders. The bioactivity of the prepared composite samples is evaluated in an in vitro study by immersion of samples in simulated body fluid (SBF) for predicted time. Fourier transformed infrared (FTIR) spectroscopy and inductively coupled plasma (ICP) are used for evaluation of apatite formation and the bioactivity properties. Results show that HA-BG composite nanopowders are successfully prepared without any decomposition of hydroxyapatite. The suitable temperature for calcination is 600°C and the particle size of hydroxyapatite is about 40-70 nm. The apatite phase forms after 14 days immersing of the samples in SBF. It could be concluded that this process can be used to synthesize HA-BG composite nanopowders with improved bioactivity which is much needed for hard tissue repair and biomedical applications.

Megakaryocyte-driven changes in bone health: lessons from mouse models of myelofibrosis and related disorders

2021 ◽  
Author(s):  
Mariya Stavnichuk ◽  
Svetlana V. Komarova
Keyword(s):  
Bone Marrow ◽  
Mouse Models ◽  
Cell Function ◽  
Bone Cells ◽  
Bone Marrow Cells ◽  
Bone Cell ◽  
Bone Architecture ◽  
Bone Homeostasis

Over the years, numerous studies demonstrated reciprocal communications between processes of bone marrow hematopoiesis and bone remodeling. Megakaryocytes, rare bone marrow cells responsible for platelet production, were demonstrated to be involved in bone homeostasis. Myelofibrosis, characterized by an increase in pleomorphic megakaryocytes in the bone marrow, commonly leads to the development of osteosclerosis. In vivo, an increase in megakaryocyte number was shown to result in osteosclerosis in GATA-1low, NF-E2-/-, TPOhigh, Mpllf/f;PF4cre, Lnk-/-, Mpig6b-/-, Mpig6bfl/fl;Gp1ba-Cr+/KI, Pt-vWD mouse models. In vitro, megakaryocytes stimulate osteoblast proliferation and have variable effects on osteoclast proliferation and activity through soluble factors and direct cell-cell communications. Intriguingly, new studies revealed that the ability of megakaryocytes to communicate with bone cells is affected by the age and sex of animals. This mini-review summarises changes seen in bone architecture and bone cell function in mouse models with an elevated number of megakaryocytes and the effects megakaryocytes have on osteoblasts and osteoclasts in vitro, and discusses potential molecular players that can mediate these effects.

Fast Apatite-Forming Ability of Magnetron Co-Sputtered Silicon-Containing Hydroxyapatite (Si-HA) Thin Films

2005 ◽  
Vol 284-286 ◽  
pp. 445-448 ◽  
Author(s):  
E.S. Thian ◽  
Jie Huang ◽  
Serena Best ◽  
Zoe H. Barber ◽  
William Bonfield
Keyword(s):  
Thin Films ◽  
Time Frame ◽  
Apatite Layer ◽  
Apatite Formation ◽  
The Novel ◽  
Processing Conditions ◽  
X Ray Diffraction ◽  
X Ray ◽  
And Control ◽  
Bone Apatite

0.8 wt.% silicon-containing hydroxyapatite (Si-HA) thin films of thickness 600 nm have been successfully developed using a magnetron co-sputtering technique, through careful selection and control of the processing conditions. These films were immersed in simulated body fluid (SBF) to investigate the nucleation and growth of an apatite layer on their surfaces. A newly-formed apatite layer with similar characteristics to that of the biological bone apatite, was observed after 4 days of immersion in SBF. X-ray diffraction and infrared analyses confirmed this layer to be calciumdeficient micro-crystalline carbonate HA. These results demonstrated that the novel Si-HA films were highly bioactive and the time frame required for apatite formation was reduced by approximately 76 % (from 17 days to 4 days).

Sign in / Sign up

Export Citation Format

Share Document